IN8bio Announces Presentation Of New Preclinical Data For Gamma-Delta NsCAR-T Cell Therapy Platform At AACR 2024; Says 'Preclinical Data Supports Potential for Proprietary NsCAR Platform to Selectively Eliminate Cancer Cells While Preserving Healthy Tissue'
in8bio宣布在2024年的AACR上公布伽玛-德尔塔NSCAR-T细胞疗法平台的新临床前数据；表示 “临床前数据支持专有NSCAR平台在保护健康组织的同时有选择地消灭癌细胞的潜力”